ArticleBMC oral health2026
Assessment of chlorhexidine combined with a Periplaneta americana extract mouthwash for preventing peri-implant diseases: a retrospective comparative study.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimPeri-implant diseases are common oral complications associated with implant-supported rehabilitation and are characterized by inflammatory conditions of peri-implant tissues induced by bacterial biofilms, including peri-implant mucositis and peri-implantitis. Although numerous studies have focused on therapeutic approaches, comparatively fewer investigations have addressed preventive strategies. This study aimed to evaluate the preventive effect of chlorhexidine combined with a Periplaneta americana extract mouthwash on peri-implant diseases.
methodsThis retrospective study included patients who underwent dental implant surgery at the Department of Stomatology, Henan Provincial People’s Hospital, between January 2022 and December 2024. According to postoperative supportive peri-implant care (SPIC) regimens, patients were divided into three groups: (1) clean water rinsing, (2) chlorhexidine mouthwash (during the first 4 weeks post-implantation), and (3) chlorhexidine (during the first 4 weeks post-implantation) combined with Periplaneta americana extract mouthwash (during the first 2 weeks post-implantation). The primary effectiveness endpoint was the incidence of peri-implant diseases at 6 months postoperatively.
resultsA total of 1,268 patients (1,819 implants) were screened, of whom 682 patients (956 implants) were included in the final analysis: 106 patients in the clean water rinsing control group (149 implants), 450 patients in the chlorhexidine group (623 implants), and 126 patients in the chlorhexidine plus Periplaneta americana group (184 implants). The proportions of male patients were 66.0% (70/106), 71.3% (321/450), and 63.5% (80/126), respectively, with mean ages of 60.6 ± 7.2, 60.1 ± 8.1, and 60.4 ± 7.4 years. At 6 months postoperatively, the incidence of peri-implant mucositis was 18.9% (20/106), 10.2% (46/450), and 2.4% (3/126), respectively, with statistically significant differences among the groups (all p < 0.05). In contrast, the incidence of peri-implantitis was 1.9% (2/106), 1.1% (5/450), and 0% (0/126), respectively, with no statistically significant differences among the groups (all p > 0.05).
conclusionsThis retrospective study provides evidence that the adjunctive use of chlorhexidine and Periplaneta americana extract mouthwash may reduce the incidence of peri-implant mucositis at 6 months postoperatively. Further prospective studies and mechanistic investigations are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.